Health

Results: 1201-1212 of 10138

Revolune Announces Commercial Availability of Multiplex Immunofluorescence Reagents

Halia Therapeutics Receives FDA Fast Track Designation for Ofirnoflast (HT-6184) in Lower-Risk Myelodysplastic Syndromes

KFSH Highlights Provider Transformation Through Measurable Operational Impact at HLTH Europe 2026

Biocytogen Earns Full AAALAC Accreditation, Reinforcing Excellence in Translational Research and Drug Discovery

Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe

Nabsys Announces Advancements in Detection of Repeat Contraction and Expansion Disorders Via Electronic Genome Mapping in Collaboration with Leading European Institutions

SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements

KFSH Presents Applied Radiology AI Model at HLTH Europe 2026

Michael Dabrowski, Chief Executive Officer of Pelago Bioscience

Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry

Lundbeck presents new Phase II asedebart data in Cushing's disease at ENDO 2026

Azafaros to Present at BIO International Convention 2026

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress